Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Regencell Bioscience Holdings Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 5 | 14 | +9 |
| Shares | 8.83K | 691.7K | +682.9K (+7,733.7%) |
| Value | $281.3K | $11.8M | +$11.5M (+4,090.5%) |
New holders (11)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 99,843 | $1.70M | 0.00% |
| Schonfeld Strategic Advisors LLC | 52,100 | $887.8K | 0.01% |
| BNP Paribas Arbitrage, SA | 45,050 | $767.7K | 0.00% |
| UBS Group AG | 37,527 | $639.5K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 13,042 | $222.2K | 0.01% |
| Greenfield Savings Bank | 11,000 | $187.4K | 0.09% |
| Advisor Group Holdings, Inc. | 190 | $3.24K | 0.00% |
| Bank of America Corp | 100 | $1.70K | 0.00% |
| Raymond James Financial Inc | 71 | $1.21K | 0.00% |
| Citigroup Inc | 70 | $1.19K | 0.00% |
| Farther Finance Advisors, LLC | 50 | $852 | 0.00% |
Sold out (2)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Royal Bank of Canada | 948 | $30.0K |
| Tower Research Capital LLC (TRC) | 698 | $22.3K |